Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016-2018: A hidden Markov modelling study.
Adolescent
Adult
Algorithms
Carrier State
/ epidemiology
Child
Child, Preschool
Computational Biology
Female
HIV Infections
/ complications
Humans
Male
Markov Chains
Middle Aged
Models, Statistical
Pneumococcal Infections
/ complications
South Africa
/ epidemiology
Streptococcus pneumoniae
Young Adult
Journal
PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
20
05
2021
accepted:
24
11
2021
entrez:
23
12
2021
pubmed:
24
12
2021
medline:
12
2
2022
Statut:
epublish
Résumé
Human immunodeficiency virus (HIV) infected adults are at a higher risk of pneumococcal colonisation and disease, even while receiving antiretroviral therapy (ART). To help evaluate potential indirect effects of vaccination of HIV-infected adults, we assessed whether HIV-infected adults disproportionately contribute to household transmission of pneumococci. We constructed a hidden Markov model to capture the dynamics of pneumococcal carriage acquisition and clearance observed during a longitudinal household-based nasopharyngeal swabbing study, while accounting for sample misclassifications. Households were followed-up twice weekly for approximately 10 months each year during a three-year study period for nasopharyngeal carriage detection via real-time PCR. We estimated the effect of participant's age, HIV status, presence of a HIV-infected adult within the household and other covariates on pneumococcal acquisition and clearance probabilities. Of 1,684 individuals enrolled, 279 (16.6%) were younger children (<5 years-old) of whom 4 (1.5%) were HIV-infected and 726 (43.1%) were adults (≥18 years-old) of whom 214 (30.4%) were HIV-infected, most (173, 81.2%) with high CD4+ count. The observed range of pneumococcal carriage prevalence across visits was substantially higher in younger children (56.9-80.5%) than older children (5-17 years-old) (31.7-50.0%) or adults (11.5-23.5%). We estimate that 14.4% (95% Confidence Interval [CI]: 13.7-15.0) of pneumococcal-negative swabs were false negatives. Daily carriage acquisition probabilities among HIV-uninfected younger children were similar in households with and without HIV-infected adults (hazard ratio: 0.95, 95%CI: 0.91-1.01). Longer average carriage duration (11.4 days, 95%CI: 10.2-12.8 vs 6.0 days, 95%CI: 5.6-6.3) and higher median carriage density (622 genome equivalents per millilitre, 95%CI: 507-714 vs 389, 95%CI: 311.1-435.5) were estimated in HIV-infected vs HIV-uninfected adults. The use of ART and antibiotics substantially reduced carriage duration in all age groups, and acquisition rates increased with household size. Although South African HIV-infected adults on ART have longer carriage duration and density than their HIV-uninfected counterparts, they show similar patterns of pneumococcal acquisition and onward transmission.
Identifiants
pubmed: 34941865
doi: 10.1371/journal.pcbi.1009680
pii: PCOMPBIOL-D-21-00940
pmc: PMC8699682
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009680Subventions
Organisme : Wellcome Trust
ID : 208812/Z/17/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2011;6(11):e27929
pubmed: 22140487
AIDS. 2001 May 25;15(8):957-64
pubmed: 11399977
PLoS One. 2013 Nov 04;8(11):e78592
pubmed: 24223825
Lancet Glob Health. 2021 Jun;9(6):e863-e874
pubmed: 34019838
Lancet. 2009 Sep 12;374(9693):893-902
pubmed: 19748398
PLoS Pathog. 2017 Dec 21;13(12):e1006665
pubmed: 29267378
Am J Epidemiol. 2013 Dec 1;178(11):1629-37
pubmed: 24091888
Ecol Lett. 2020 Dec;23(12):1878-1903
pubmed: 33073921
Lancet. 2019 May 25;393(10186):2146-2154
pubmed: 31000194
PLoS Comput Biol. 2019 Dec 26;15(12):e1007589
pubmed: 31877122
AIDS. 2015 Sep 10;29(14):1837-44
pubmed: 26218599
Bull World Health Organ. 2016 Oct 1;94(10):772-776
pubmed: 27843168
J Infect Dis. 2008 Apr 1;197(7):1000-5
pubmed: 18419536
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
J Clin Microbiol. 2007 Oct;45(10):3408-10
pubmed: 17699645
BMC Med. 2020 Jun 10;18(1):129
pubmed: 32517683
PLoS One. 2012;7(5):e38271
pubmed: 22693610
Hum Vaccin Immunother. 2012 Feb;8(2):161-73
pubmed: 22426374
BMC Public Health. 2016 Sep 06;16:938
pubmed: 27600800
PLoS One. 2011 Mar 15;6(3):e17765
pubmed: 21423577
Am J Epidemiol. 2019 Jan 1;188(1):160-168
pubmed: 30462150
Expert Rev Vaccines. 2020 Nov;19(11):1085-1092
pubmed: 33269987
Vaccine. 2018 Nov 19;36(48):7369-7376
pubmed: 30352744
BMC Med. 2019 Dec 5;17(1):219
pubmed: 31801542
Epidemiol Infect. 2017 Oct;145(13):2750-2758
pubmed: 28847317
Elife. 2017 Jul 25;6:
pubmed: 28742023
Travel Med Infect Dis. 2018 Jul - Aug;24:89-100
pubmed: 29860151
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
Am J Epidemiol. 2007 Jul 15;166(2):228-35
pubmed: 17517684
Epidemiol Infect. 2005 Oct;133(5):891-8
pubmed: 16181510
Vaccine. 2015 Aug 26;33(36):4430-6
pubmed: 26141012
Pediatr Infect Dis J. 2018 Oct;37(10):1054-1060
pubmed: 30216295
Epidemiol Infect. 2017 Aug;145(11):2390-2399
pubmed: 28712384
Stat Med. 2002 Jan 15;21(1):113-28
pubmed: 11782054
Drugs. 2008;68(11):1473-81
pubmed: 18627205
Am J Epidemiol. 2016 Jan 1;183(1):70-8
pubmed: 26628514
J Infect Dis. 2005 Jun 15;191(12):2038-45
pubmed: 15897989
Influenza Other Respir Viruses. 2021 Nov;15(6):789-803
pubmed: 34296810
Pediatr Infect Dis J. 2013 May;32(5):e192-205
pubmed: 23340555
Clin Infect Dis. 2021 Jun 1;72(11):e768-e775
pubmed: 32989457
Med Decis Making. 2017 Oct;37(7):779-789
pubmed: 28379779
Nat Commun. 2020 May 6;11(1):2222
pubmed: 32376860
Epidemiology. 2012 Jul;23(4):510-9
pubmed: 22441543
Epidemiol Infect. 2004 Jun;132(3):433-41
pubmed: 15188713
Biostatistics. 2004 Apr;5(2):223-37
pubmed: 15054027
Pediatr Infect Dis J. 2005 May;24(5):410-6
pubmed: 15876939
Clin Infect Dis. 2019 Apr 24;68(9):1512-1521
pubmed: 30165376
Clin Infect Dis. 2011 May;52 Suppl 4:S331-7
pubmed: 21460292
Lancet. 2019 May 25;393(10186):2102-2104
pubmed: 31000193
Stat Med. 2003 Feb 15;22(3):441-62
pubmed: 12529874